In December 2025, a Silicon Laboratories insider exercised options and sold over 6,000 shares, reducing ownership by 23.46% since May 2024. The transaction was worth approximately $871,633, according to an SEC Form 4 filing. The average share price was $140.83, with shares closing at $141.52 on Dec. 5, 2025, up 10.70% in the past year.

The Sr. Vice President of Worldwide Sales & Marketing at Silicon Laboratories, Brandon Tolany, executed the sale of 6,200 employee stock options, totaling $871,630, in early December 2025. Post-transaction, Tolany holds 62,381 shares, with no indirect ownership reported. This transaction reduced his direct share count by 9.0%.

Silicon Laboratories primarily sells semiconductor solutions for IoT applications, utilizing a fabless business model. The company serves various sectors globally, such as connected home, industrial automation, consumer electronics, and medical instrumentation. Despite a recent share sale by a top executive, the company’s financials and stock performance are rebounding positively.

After two consecutive years of revenue losses, Silicon Labs is on track for a rebound in FY2025, with a 47% YoY increase in revenue as of Oct. 4, 2025. The company posted a quarterly net loss of $9.94 million in Q3 2025, the least since Q3 2023 when it had positive net income. Insiders, including top executives, remain optimistic about the stock’s future.

Read more at Yahoo Finance: Silicone Laboratories Senior VP Sells Thousands of Shares Towards End of 2025